<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A2436</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 2436 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  ANNETTE QUIJANO</p>

<p class=bpuSponsor>District 20 (Union)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Directs Cannabis Regulatory Commission to adopt
regulations concerning labeling, marketing, and sale of cannabidiol and
products containing cannabidiol; prohibits sale of cannabidiol to minors. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning the labeling, marketing, and sale of
cannabidiol and products containing cannabidiol, supplementing Title 24 of the
Revised Statutes, and amending P.L.2019, c.238.  </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    (New section)  a.  No
later than one year after the date of the first meeting of the Cannabis
Regulatory Commission created pursuant to section 31 of P.L.2019, c.153 (C.24:6I-24)
or one year after the effective date of P.L.     , c.     (C.        ) (pending
before the Legislature as this bill), whichever is later, the Cannabis
Regulatory Commission shall, in consultation with the Department of Agriculture
and the Department of Health, and pursuant to the Administrative Procedure
Act, P.L.1968, c.410 (C.52:14B-1 et seq.), adopt rules and regulations
concerning the labeling, marketing, and sale of cannabidiol and products
containing cannabidiol, including cannabidiol or cannabidiol products produced
for ingestion, topical application, inhalation, or consumption in any form. 
The rules and regulations shall not apply to medical cannabis or medical
cannabis products cultivated, manufactured, or dispensed by an alternative
treatment center pursuant to the Jake Honig Compassionate Use Medical Cannabis
Act, P.L.2009, c.307 (C.24:6I-1 et al.).  </p>

<p class=MsoNormal style='line-height:150%'>     b.    The rules and
regulations adopted pursuant to subsection a. of this section shall include:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   health and safety
standards for cannabidiol and products containing cannabidiol including, but
not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   the permitted uses of
cannabidiol for scientific and therapeutic purposes;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   standardized recommended
amount for single use of cannabidiol;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   limits on the potency of
cannabidiol or the total amount of cannabidiol that may be contained in a
product; and </p>

<p class=MsoNormal style='line-height:150%'>     (d)   maximum single use
amount and limits for the number of single use amounts of cannabidiol that may
be sold as part of one product;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   labeling and packaging
standards for cannabidiol and products containing cannabidiol, including:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   single use amount size,
the total number of single use amounts in a package, and a statement regarding
the total amount of cannabidiol contained in the product and in each single use
amount;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   production date and
expiration date of the product; and</p>

<p class=MsoNormal style='line-height:150%'>     (c)   ingredient lists; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   advertising requirements
and limitations for cannabidiol and products containing cannabidiol including:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   prohibitions on
advertising cannabidiol and products containing cannabidiol in a manner that
appeals to minors, promotes illegal activity, or otherwise presents a risk to
public health and safety; and</p>

<p class=MsoNormal style='line-height:150%'>     (b)   limits on the health
claims that may be advertised in conjunction with cannabidiol to those
recognized by the commission pursuant to section 2 of P.L.     , c.    
(C.        ) (pending before the Legislature as this bill).  </p>

<p class=MsoNormal style='line-height:150%'>     c.     In addition to any
State or federal law, any person who violates a rule or regulation adopted
pursuant to this section shall be liable to a civil penalty of $1,000 for the
first offense and up to $2,000 for the second and each subsequent offense, to
be collected in a civil action commenced by the Cannabis Regulatory
Commission.  Any penalty imposed pursuant to this subsection may be collected
in a summary proceeding under the Penalty Enforcement Law of 1999, P.L.1999,
c.274 (C.2A:58-10 et seq.).  If the violation is of a continuing nature, each
day during which it continues shall constitute an additional, separate and
distinct offense.  The Superior Court and the municipal court shall have
jurisdiction to enforce the provisions of the Penalty Enforcement Law of 1999
pursuant to this subsection.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    (New section)  The rules
and regulations adopted pursuant to section 1 of P.L.     , c.     (C.        )
(pending before the Legislature as this bill) shall be based upon the best
available scientific data.  Any regulation related to health, safety, dosage,
or therapeutic uses of cannabidiol shall be valid if in the opinion of experts
at the Department of Health:</p>

<p class=MsoNormal style='line-height:150%'>     a.     the underlying
information has been clearly demonstrated through scientifically valid testing
according to generally accepted principles;</p>

<p class=MsoNormal style='line-height:150%'>     b.    a body considered to be
authoritative by the experts at the Department of Health has formally endorsed
the regulation or underlying information; or </p>

<p class=MsoNormal style='line-height:150%'>     c.     an agency of the State
or federal government has formally required the regulation or endorsed the
underlying information.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    (New section)  a.  Except
as authorized by the Jake Honig Compassionate Use Medical Cannabis Act,
P.L.2009, c.307 (C.24:6I-1 et al.), no person shall sell, offer for sale, or distribute
for commercial purpose at no cost or minimal cost, cannabidiol or a product
containing cannabidiol to a person under 21 years of age.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    Any person who violates
subsection a. of this section shall be liable to a civil penalty of not less
than $250 for the first violation; $500 for the second violation; and $1,000
for the third and each subsequent violation.  The penalties imposed pursuant to
this subsection <span style='letter-spacing:0pt'>shall be recovered in a
summary proceeding pursuant to the Penalty Enforcement Law of 1999, P.L.1999,
c.274 (C.2A:58-10 et seq.).  The municipal court in the municipality where the
violation occurred shall have jurisdiction to enforce the provisions of the
Penalty Enforcement Law of 1999 pursuant to this section.</span>  An official
authorized by statute or ordinance to enforce the State or local health codes
or a law enforcement officer having enforcement authority in that municipality
may issue a summons for a violation of the provisions of subsection a. of this
section, and may serve and execute all process with respect to the enforcement
of this section consistent with the Rules of Court.  A penalty recovered under
the provisions of this subsection shall be recovered by and in the name of the
State by the local health agency.  The penalty shall be paid into the treasury
of the municipality in which the violation occurred for the general uses of the
municipality.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The establishment of the
following shall constitute a defense to a violation of the provisions of
subsection a. of this section: </p>

<p class=MsoNormal style='line-height:150%'>     (1)    the purchaser of the <span
style='letter-spacing:0pt'>cannabidiol or product containing cannabidiol</span>
falsely represented that the person was of legal age to make the purchase, by
producing either a United States passport, a drivers license or non-driver
identification card issued by the New Jersey Motor Vehicle Commission, a
drivers license issued pursuant to the laws of another state, <span
style='letter-spacing:0pt'>or</span> any other identification card issued by a
state or the United States that bears a picture of the person, the name of the
person, the persons date of birth, and a physical description of the person;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   the appearance of the
purchaser of the cannabidiol or the product containing cannabidiol was such
that an ordinary prudent person would believe the purchaser to be of legal age
to make the purchase; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   the sale or distribution
was made in good faith, relying upon the production of identification that
conforms to the standards enumerated in paragraph (1) of this subsection and
the reasonable belief that the purchaser or recipient was actually of legal age
to make the purchase. </p>

<p class=MsoNormal style='line-height:150%'>     d.    It shall be unlawful for
a person under the age of 21 to present or offer any written or oral evidence
of age <span style='letter-spacing:0pt'>or other personal identifying
information</span> that is false, fraudulent, or not actually the persons own,
<span style='letter-spacing:0pt'>including the use of a drivers license or
other government-issued form of identification in violation of section 1 of
P.L.1983, c.565 (C.2C:21-2.1), N.J.S.2C:21-17, section 5 of P.L.2003, c.184
(C.2C:21-17.2), or section 6 of P.L.1968, c.313 (C.33:1-81.7),</span> for the
purpose of purchasing, attempting to purchase, or otherwise procuring or
attempting to procure <span style='letter-spacing:0pt'>cannabidiol or a product
containing cannabidiol</span>.</p>

<p class=MsoNormal style='line-height:150%'>     e.     The prohibitions of
this section do not apply to a person under the legal age for purchasing <span
style='letter-spacing:0pt'>cannabidiol</span> who is acting under the direction
of the commission or under the direction of a State or local law enforcement
agency for the purpose of investigating possible violations of the laws
prohibiting the sale of <span style='letter-spacing:0pt'>cannabidiol</span> to
persons who are under the legal age for purchasing <span style='letter-spacing:
0pt'>cannabidiol</span>. </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    (New section)  Nothing
in P.L.     , c.     (C.        ) (pending before the Legislature as this bill)
shall be construed to limit any privileges or rights of a registered qualifying
patient, designated caregiver, institutional caregiver, or alternative
treatment center as provided in the Jake Honig Compassionate Use Medical
Cannabis Act, P.L.2009, c.307 (C.24:6I-1 et al.) and P.L.2015, c.158
(C.18A:40-12.22 et al.) concerning the medical use of cannabis.  </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    (New section)  The
provisions of P.L.     , c.     (C.        ) (pending before the Legislature as
this bill) shall not apply to:</p>

<p class=MsoNormal style='line-height:150%'>     a.     a product containing
cannabidiol that is approved or licensed by the federal Food and Drug
Administration under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
s.301 et seq. and used in an approved manner; or </p>

<p class=MsoNormal style='line-height:150%'>     b.    a product that is
generally recognized as safe and effective pursuant to conditions established
by the federal Food and Drug Administration and any applicable regulations.  </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    Section 9 of P.L.2019,
c.238 (C.24:5-23) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     9.    a.  A State agency may
not prohibit a person or business entity that processes or manufactures a
product regulated by the agency from applying for or obtaining a permit or
other authorization to process or manufacture the product solely on the basis
that the person or business entity intends to process or manufacture the
product with hemp.</p>

<p class=MsoNormal style='line-height:150%'>     b.    Hemp, hemp products, and
hemp derivatives, including hemp-derived cannabidiol, produced in accordance
with P.L.2019, c.238 (C.4:28-6 et al.) and any rules or regulations adopted
pursuant thereto, shall not be considered controlled substances or additives <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and hemp,<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>  <u>.  Hemp,</u>
hemp products, or hemp derivatives, including hemp-derived cannabidiol <u>,</u>
may be added as an ingredient to cosmetics, personal care products, or products
intended for human or animal consumption <u>pursuant to P.L.2019, c.238
(C.4:28-6 et al.) and P.L.     , c.     (C.        ) (pending before the
Legislature as this bill)</u> .</p>

<p class=MsoNormal style='line-height:150%'>     c.     The provisions of
P.L.2019, c.238 (C.4:28-6 et al.) applicable to hemp producers shall not apply
to the possession, handling, transport, or sale of hemp products, including
those containing one or more hemp-derived cannabinoids, including cannabidiol.
Notwithstanding any other law, a person or business entity may possess,
transport, sell, and purchase legally produced hemp products in this State <u>pursuant
to P.L.2019, c.238 (C.4:28-6 et al.) and P.L.     , c.     (C.        )
(pending before the Legislature as this bill)</u> .  As part of the rules and
regulations adopted pursuant to P.L.2019, c.238 (C.4:28-6 et al.) <u>and
section 1 of P.L.     , c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill)</u> , the Department of
Agriculture <u>or the Cannabis Regulatory Commission created pursuant to
section 31 of P.L.2019, c.153 (C.24:6I-24), as applicable,</u> shall provide to
a retailer of hemp products notice of a potential violation concerning hemp
products sold by the retailer and shall provide an opportunity to cure a
violation committed unintentionally or negligently.</p>

<p class=MsoNormal style='line-height:150%'>     d.    The Department of
Agriculture, in consultation with the Department of Health <u>and the Cannabis
Regulatory Commission created pursuant to section 31 of P.L.2019, c.153
(C.24:6I-24)</u> , may adopt rules and regulations only to regulate the sale of
hemp products that <u>do not conflict with the rules and regulations adopted
pursuant section 1 of P.L.     , c.     (C.        ) (pending before the
Legislature as this bill) and that</u> provide that:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   hemp-derived
cannabinoids, including cannabidiol, are not considered controlled substances
or adulterants; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   products containing one
or more hemp-derived cannabinoids, such as cannabidiol, intended for ingestion
are to be considered foods, not controlled substances or adulterated products
to the maximum extent permitted by federal law.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Retail sales of hemp
products processed outside the State may be conducted in the State when the
products and the hemp used in the products were processed and cultivated
legally in another state or jurisdiction that has the same or substantially
similar requirements for processing hemp products or cultivating hemp as
provided by P.L.2019, c.238 (C.4:28-6 et al.) <u>and, if applicable, the
requirements for packaging, labeling, advertising, and approved uses of
cannabidiol and products containing cannabidiol established pursuant to section
1 of P.L.     , c.     (C.        ) (pending before the Legislature as this
bill)</u> .</p>

<p class=MsoNormal style='line-height:150%'>     f.     Hemp products may be
legally transported across State lines and exported to foreign countries in a
manner that is consistent with federal law and the laws of respective foreign
countries.</p>

<p class=MsoNormal style='line-height:150%'>(cf:  P.L.2019, c.238, s.9)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    This act shall take
effect immediately.  </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill would direct the
Cannabis Regulatory Commission to adopt regulations concerning labeling,
marketing, and sale of cannabidiol and products containing cannabidiol, and
would prohibit the sale of cannabidiol to minors.</p>

<p class=MsoNormal style='line-height:150%'>     The bill would require the
Cannabis Regulatory Commission, in consultation with the Department of
Agriculture and the Department of Health, to adopt rules and regulations
concerning the labeling, marketing, and sale of cannabidiol and products
containing cannabidiol, including products intended to be ingested, applied
topically, inhaled, or consumed in any form.  The rules and regulations would
include (1) health and safety standards for cannabidiol and products containing
cannabidiol including permitted uses of cannabidiol, standardized single use
amounts for cannabidiol, limits on potency, and maximum single use amount; (2)
labeling and packaging standards for cannabidiol and products containing
cannabidiol including single use amount, the total number of single use amounts
in a package, and a statement regarding the total amount of cannabidiol
contained in the product and in each serving; and (3) advertising requirements
for cannabidiol and products containing cannabidiol, including a prohibition on
the advertising products to minors or in ways that may risk health and safety,
and limits on the health claims that may be advertised in conjunction with
cannabidiol to allow only those recognized by the commission.</p>

<p class=MsoNormal style='line-height:150%'>     Any  rule or regulation
adopted by the commission would be based upon the best available scientific
data.  Any regulation related to health, safety, dosage, or therapeutic claims
would be valid if: (1) the underlying information has been clearly demonstrated
through scientifically valid testing according to generally accepted
principles;</p>

<p class=MsoNormal style='line-height:150%'>(2) a body considered to be
authoritative by the Department of Health has formally endorsed the regulation
or underlying information; or (3) an agency of the State or federal government
has formally required the regulation or endorsed the underlying information.</p>

<p class=MsoNormal style='line-height:150%'>     The bill would prohibit the
sale of cannabidiol and products containing cannabidiol to minors, and would
establish a penalty of $250 for the first violation; $500 for the second
violation; and $1,000 for the third and each subsequent violation.  Any
violations of the rules and regulations established by the Cannabis Regulatory
Commission concerning the labeling, marketing, and sale of cannabidiol and
products containing cannabidiol would be subject to a civil penalty of $1,000
for the first offense and up to $2,000 for the second and each subsequent
offense.   </p>

<p class=MsoNormal style='line-height:150%'>     The bill would not limit any
privileges or rights of a registered qualifying patient, designated caregiver,
institutional caregiver, or alternative treatment center as provided in the
Jake Honig Compassionate Use Medical Cannabis Act.  The bill would also not
apply to a product containing cannabidiol that is licensed or approved by the
federal Food and Drug Administration under the Federal Food, Drug, and
Cosmetic Act, and used in an approved manner.  </p>

<p class=MsoNormal style='line-height:150%'>     The bill would amend the New
Jersey Hemp Farming Act, P.L.2019, c.238 (4:28-6 et al.) to ensure that the
rules and regulations adopted by the Cannabis Regulatory Commission would not
conflict with the rules and regulations adopted by the Department of Agriculture
to regulate the cultivation, handling, processing, transport, and sale of hemp
and hemp products.  </p>

</div>

</body>

</html>
